scientific article; zbMATH DE number 1984442

zbMATH Open1022.62109MaRDI QIDQ4428801FDOQ4428801

Author name not available (Why is that?)

Publication date: 22 September 2003

Title of this publication is not available (Why is that?)

Recommendations

Adaptive Bayesian compound designs for dose finding studies
Bayesian adaptive designs for clinical trials
A Bayesian adaptive design in clinical trials for continuous responses
scientific article
A Bayesian adaptive design in cancer phase I trials using dose combinations in the presence of a baseline covariate
Bayesian design for clinical trials with a constraint on the total available dose
Bayesian adaptive methods for clinical trials
Adaptive Bayesian phase I clinical trial designs for estimating the maximum tolerated doses for two drugs while fully utilizing all toxicity information

Bayesian inference (62F15) Applications of statistics to biology and medical sciences; meta analysis (62P10) Sequential statistical design (62L05) Bayesian problems; characterization of Bayes procedures (62C10)

Cited In (20)

Min-Max Optimal Design of Two-Armed Trials with Side Information
Flexible link continual reassessment methods for trivariate binary outcome phase I/II trials
Optimal stopping for response-guided dosing
Title not available (Why is that?)
Easy-to-implement Bayesian methods for dose-escalation studies in healthy volunteers
Dynamic Programming for Response-Adaptive Dose-Finding Clinical Trials
Bayesian design for clinical trials with a constraint on the total available dose
Adaptive isotonic estimation of the minimum effective and peak doses in the presence of covariates
Population modelling of patient responses in antidepressant studies: a stochastic approach
Implementation of a Bayesian Design in a Dose‐Escalation Study of an Experimental Agent in Healthy Volunteers
Simulation-based sequential Bayesian design
Bayesian statistics and the efficiency and ethics of clinical trials
Approximating the operating characteristics of Bayesian uncertainty directed trial designs
Celebrating 70: an interview with Don Berry
Phase I (or Phase II) Dose-Ranging Clinical Trials: Proposal of a Two-Stage Bayesian Design
Adaptive Bayesian phase I clinical trial designs for estimating the maximum tolerated doses for two drugs while fully utilizing all toxicity information
A combined proof of concept and dose finding study with multiple endpoints: A Bayesian adaptive design in chronic prostatitis/chronic pelvic pain syndrome
Incorporating Bayesian ideas into health-care evaluation
Bayesian decision procedures based on logistic regression models for dose-finding studies
A review of phase 2-3 clinical trial designs

This page was built for publication:

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4428801)